Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort

PURPOSE: Although non-small cell lung cancer (NSCLC) remains a deadly disease, new predictive biomarkers have emerged to assist in managing the disease, of which one of the most promising is the programmed death‐ligand 1 (PD-L1). Each, PD-L1 variant seem to modulate the function of immune checkpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado-Rugolo, Juliana, Gutierrez Prieto, Tabatha, Fabro, Alexandre Todorovic, Parra Cuentas, Edwin Roger, Sá, Vanessa Karen, Baldavira, Camila Machado, Rainho, Claudia Aparecida, Castelli, Erick C, Farhat, Cecilia, Takagaki, Teresa Yae, Nagai, Maria Aparecida, Capelozzi, Vera Luiza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894801/
https://www.ncbi.nlm.nih.gov/pubmed/33623414
http://dx.doi.org/10.2147/PGPM.S286717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894801/
https://www.ncbi.nlm.nih.gov/pubmed/33623414
http://dx.doi.org/10.2147/PGPM.S286717

Ejemplares similares